drugset / Trial / NCT03024008

Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II

NCT03024008 ↗

Phase 1/2 Recruiting 40 enrolled BonusBio Group Ltd
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this clinical study is to evaluate the safety and the efficacy of BonoFill-II as an autologous bone-regenerating graft in the reconstruction of deficient bone in two clinical indications: 1. Long and short bone extra-articular comminuted fracture 2. Long and short bones extra and intra articular defect /Gap or non-union, incapable of self-regeneration

Timeline

Start
2017-07-27
Primary completion
2027-03
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject BonoFill-II Cell therapy — Other